COVID‐19 infection in children and adolescents with cancer in Madrid

Abstract

far, with mild-moderate disease, and only two of them required oxygen therapy, in line with general pediatric population data. 3 In conclusion, the prevalence of COVID-19 infection among children with cancer in Madrid is 1.3%. Although this patient population is managed as high risk, the clinical features are milder and the prognosis better than in the adult population.

Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS‐CoV‐2 pandemic

“…Most of the reported patients (68%) were from the states of Madrid and Catalonia, the two most affected areas in Spain 13 . Fifteen of the patients included in the present study were previously reported recently by de Rojas et al 14 . Initial experiences from Italy (Lombardy), 15 China (Wuhan), 16,17 and Europe suggest a low number and severity of COVID‐19 cases in this patient population, 6 contrary to France, where a higher incidence of critical patients was observed 18 .…”

COVID‐19 in pediatric hematopoietic stem cell transplantation: The experience of Spanish Group of Transplant (GETMON/GETH)

“…So, the incidence of COVID-19 in children with cancer in Madrid has recently been reported and is 1.3% higher than in the general pediatric population. 2 Table 1. We identified eight children with a median age of 10 years old (range 1-12), which is an incidence of 3% of the pediatric HSCT performed annually in Spain.…”

Impact of Covid19 on a tertiary care pediatric oncology and stem cell transplant unit in Riyadh, Saudi Arabia

“…Despite the concerns that chemotherapy-related immunosuppression is a risk factor to develop severe disease with Covid19, there is growing evidence that coronavirus-related mortality is extremely rare in pediatric cancer patients. 5,9,10 in pediatric cancer patients warrants that we reconsider our approach to the design of pediatric cancer services in the event of a second peak of Covid19 and future such pandemics. 12…”